title: The current status and future applications of interleukin 2- and adoptive immunotherapy in cancer treatment.
authors.forename: C
authors.initials: C
authors.lastname: Simpson
authors.forename: C A
authors.initials: CA
authors.lastname: Seipp
authors.forename: S A
authors.initials: SA
authors.lastname: Rosenberg
mesh_terms: D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000627:therapeutic use* / Q000633:toxicity; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use*
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins